Sang Soo Kim Selected Research

Thyroiditis

1/2012	Factors associated with the development of new onset diffuse thyroid F18-fluorodeoxyglucose uptake after treatment of breast cancer in patients without a history of thyroid disease or thyroid dysfunction.
9/2011	Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma: the influence of lymph node metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sang Soo Kim Research Topics

Disease

43	Neoplasms (Cancer) 10/2023 - 11/2004
32	Type 2 Diabetes Mellitus (MODY) 11/2023 - 02/2011
13	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 06/2010
10	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 10/2008
10	Papillary Thyroid Cancer 02/2019 - 04/2012
8	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 03/2013
8	Insulin Resistance 01/2020 - 06/2013
7	Carcinogenesis 08/2020 - 11/2004
7	Albuminuria 08/2017 - 02/2011
6	Lymphatic Metastasis 10/2021 - 06/2011
6	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2012
6	Chronic Renal Insufficiency 09/2018 - 02/2011
5	Neoplasm Metastasis (Metastasis) 08/2020 - 11/2011
5	Diabetes Mellitus 09/2018 - 09/2013
4	Body Weight (Weight, Body) 01/2021 - 11/2004
4	Pancreatic Neoplasms (Pancreatic Cancer) 12/2020 - 11/2011
4	Obesity 12/2019 - 09/2013
3	Dyslipidemias (Dyslipidemia) 11/2023 - 09/2011
3	Lung Neoplasms (Lung Cancer) 10/2023 - 08/2006
3	Peripheral Nervous System Diseases (PNS Diseases) 11/2022 - 12/2012
3	Hypoglycemia (Reactive Hypoglycemia) 02/2022 - 04/2017
3	Brain Neoplasms (Brain Tumor) 01/2020 - 05/2015
3	Liver Neoplasms (Liver Cancer) 02/2012 - 10/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 08/2020
2	Atherosclerosis 01/2021 - 12/2012
2	Goiter 01/2020 - 05/2015
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2019
2	Fibrosis (Cirrhosis) 01/2020 - 09/2018
2	Osteoporosis 02/2019 - 11/2018
2	Hyperglycemia 01/2019 - 01/2017
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2018 - 01/2018
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017 - 01/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016 - 10/2007
2	Vitamin D Deficiency 01/2016 - 03/2015
2	Proteinuria 11/2014 - 03/2013
2	Hypertension (High Blood Pressure) 03/2014 - 09/2011
2	Abdominal Obesity 06/2013 - 01/2013
2	Prostatic Neoplasms (Prostate Cancer) 01/2013 - 01/2013
2	Thyroiditis 01/2012 - 09/2011
2	Hyperplasia 09/2006 - 11/2004

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 10/2023 - 11/2004
12	Biomarkers (Surrogate Marker)IBA 10/2021 - 06/2010
8	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 11/2012
8	AlbuminsIBA 09/2022 - 02/2011
7	Insulin (Novolin)FDA Link 01/2020 - 11/2012
6	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 06/2016
6	IodineIBA 01/2022 - 03/2015
6	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022 - 01/2012
6	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2020 - 06/2011
6	Protein Isoforms (Isoforms)IBA 01/2020 - 09/2006
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 12/2015
5	LipidsIBA 01/2021 - 11/2012
5	CreatinineIBA 02/2017 - 02/2011
4	Protons (Proton)IBA 12/2020 - 02/2011
4	ClusterinIBA 01/2020 - 08/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 11/2004
4	Vitamin D FDA LinkGeneric 01/2016 - 06/2013
4	Indicators and Reagents (Reagents)IBA 12/2015 - 11/2011
4	Transforming Growth Factor beta (TGF-beta)IBA 05/2011 - 06/2006
3	NAD (NADH)IBA 11/2022 - 12/2012
3	Thyroid HormonesIBA 01/2022 - 12/2019
3	Small Interfering RNA (siRNA)IBA 08/2020 - 10/2008
3	Pioglitazone (Actos)FDA Link 01/2020 - 06/2016
3	Streptozocin (Streptozotocin)FDA Link 09/2018 - 01/2017
3	Matrix Metalloproteinase 2 (Gelatinase A)IBA 09/2018 - 01/2017
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017 - 05/2011
3	hydroxide ionIBA 03/2015 - 06/2013
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2013 - 12/2012
2	Messenger RNA (mRNA)IBA 10/2023 - 02/2012
2	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 01/2019
2	LC15-0444IBA 01/2023 - 11/2020
2	AntibodiesIBA 01/2023 - 01/2012
2	BilirubinIBA 09/2022 - 09/2017
2	Estrogens (Estrogen)FDA Link 01/2021 - 01/2018
2	Hormones (Hormone)IBA 01/2021 - 01/2018
2	glimepiride (Amarel)FDA LinkGeneric 01/2020 - 04/2017
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 01/2020
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020 - 06/2016
2	Interleukin-18 (Interleukin 18)IBA 01/2019 - 08/2012
2	CateninsIBA 01/2018 - 01/2016
2	Cyclin D1IBA 01/2018 - 01/2009
2	AngiotensinogenIBA 05/2017 - 08/2012
2	LigandsIBA 05/2015 - 09/2013
2	CatecholaminesIBA 12/2014 - 09/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2013 - 06/2010
2	Fluorine-18IBA 09/2013 - 06/2010
2	Cystatin CIBA 03/2013 - 02/2011
2	AntigensIBA 12/2011 - 11/2011
2	CarbohydratesIBA 12/2011 - 11/2011
1	Ezetimibe (Zetia)FDA Link 11/2023
1	Rosuvastatin Calcium (Crestor)FDA Link 11/2023

Therapy/Procedure

19	Therapeutics 10/2023 - 01/2013
12	Radiotherapy 01/2021 - 08/2010
10	Proton Therapy 11/2022 - 02/2011
10	Thyroidectomy 12/2020 - 06/2011
5	Glycemic Control 02/2022 - 12/2015
3	Chemoradiotherapy 01/2019 - 11/2011
2	Adjuvant Chemoradiotherapy 01/2019 - 12/2011
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 11/2015 - 03/2015
2	Aftercare (After-Treatment) 01/2012 - 11/2004